Motor Function and Growth Outcomes With Early Corticosteroid Initiation in Duchenne Muscular Dystrophy: An Adjusted Cross‐Trial Comparison
Muscle & Nerve · 2026-06 · 73 (6) · 1073-1081
DOI: 10.1002/mus.70201 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Muscle & Nerve, online erschienen am 20.03.2026. Verfasst von Emma Ciafaloni und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Rochester School of Medicine, Rochester, New York, USA. Hauptthemen laut MEDLINE: Adrenal Cortex Hormones, Motor Activity, Muscular Dystrophy, Duchenne. Die Arbeit nennt 19 Literaturangaben. Gefördert von: Parent Project Muscular Dystrophy.
Abstract (Originalsprache)
Introduction/Aims Corticosteroids improve muscle strength and motor function in Duchenne muscular dystrophy (DMD) and are essential to the standard of care. We aimed to quantify effects of earlier versus later corticosteroid initiation on modern measures of motor function among younger patients for whom timeliness of diagnosis, and thus opportunity for treatment, is variable.
Methods
We compared patients with DMD aged 4 to < 8 years initiating daily corticosteroids at trial baseline ( n = 114; FOR‐DMD [NCT01603407]) to those not initiating ( n = 42; PolarisDMD [NCT03703882]). Changes in motor function, weight, and height were compared over 12 months between these groups. Baseline prognostic factors were balanced via propensity score weighting.
Results
Initiating daily corticosteroids was associated with significantly better 12‐month motor function outcomes compared to not initiating, with mean (95% confidence interval) differences of 6.9 (5.5, 8.3) North Star Ambulatory Assessment (NSAA) points, 0.47 (0.36, 0.59) meters/s for 10 m walk/run, and 0.10 (0.08, 0.12) tasks/s for rise from supine, each exceeding minimal clinically important differences. Benefits were consistent across baseline age and motor function subgroups. Weight gain was similar and height gain was lower among corticosteroid‐treated patients by 2.0 (1.3, 2.7) cm.
Discussion
Given persistent delays between symptom onset and diagnosis in DMD, which contribute to an average diagnosis age of 5 years, these findings underscore the importance of earlier diagnosis to allow time for informed discussions about corticosteroids and to optimize meaningful functional benefits during early developmental years.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University of Rochester School of Medicine, Rochester, New York, USA.
- Analysis Group Inc., Currently Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Boston, Massachusetts, USA.
- Currently Edgewise Therapeutics, Catabasis Pharmaceuticals, Boulder, Colorado, USA.
- Parent Project Muscular Dystrophy, Washington, DC, USA.
- Translational and Clinical Research, Newcastle University, Newcastle upon Tyne, UK.
- Center for Experimental Neurotherapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
ORCID-Profile: Katherine Anderson, Robert C Griggs, James Signorovitch
Förderung
- Parent Project Muscular Dystrophy
Zitieren
APA
Ciafaloni, E., Zion, A., Donovan, J., Freed, M., Anderson, K., Guglieri, M., Finkel, R. S., Griggs, R. C., Akbarnejad, H., & Signorovitch, J. (2026). Motor Function and Growth Outcomes With Early Corticosteroid Initiation in Duchenne Muscular Dystrophy: An Adjusted Cross‐Trial Comparison. Muscle & Nerve, 73(6), 1073-1081. https://doi.org/10.1002/mus.70201
Vancouver
Ciafaloni E, Zion A, Donovan J, Freed M, Anderson K, Guglieri M, et al. Motor Function and Growth Outcomes With Early Corticosteroid Initiation in Duchenne Muscular Dystrophy: An Adjusted Cross‐Trial Comparison. Muscle & Nerve. 2026;73(6):1073-1081. doi:10.1002/mus.70201
BibTeX
@article{Ciafaloni2026,
author = {Ciafaloni, Emma and Zion, Abigail and Donovan, Joanne and Freed, Megan and Anderson, Katherine and Guglieri, Michela and Finkel, Richard S and Griggs, Robert C and Akbarnejad, Hanane and Signorovitch, James},
title = {Motor Function and Growth Outcomes With Early Corticosteroid Initiation in Duchenne Muscular Dystrophy: An Adjusted Cross‐Trial Comparison},
journal = {Muscle & Nerve},
year = {2026},
volume = {73},
number = {6},
pages = {1073--1081},
doi = {10.1002/mus.70201}
}
EUVIMED